Logo

Cepheid Shares Slide to Near 52-week Low

Sep 10, 2008
NEW YORK (GenomeWeb News) – Shares of Cepheid fell as low as $14.67 in Wednesday trade on the Nasdaq, nearing a 52-week low of $14.27.
 
The stock fell following a downgrade from investment bank Piper Jaffray from “Buy” to “Neutral.”
 
Cepheid’s shares were down 2.5 percent at $15.45 in early afternoon trade. The firm’s stock is down 41 percent since the beginning of the year.
 
Though Cepheid reported at the end of July a 55 percent increase in second-quarter revenues, the firm lowered its revenue guidance for the year to a range of between $173 million and $177 million from an earlier forecast of $183 million to $190 million.
 

Breaking News
The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.